| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $838.8M | +16.4% |
| Cost of Revenue | $126.1M | +11.3% |
| Gross Profit | $712.7M | +17.4% |
| R&D Expense | $163.2M | -0.8% |
| SG&A Expense | $141.1M | -21.9% |
| Operating Income | $13.2M | +109.5% |
| Pre-tax Income | $53.3M | +158.7% |
| Income Tax | -$130.4M | -2978.9% |
| Net Income | $183.7M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $569.8M | -8.1% |
| Short-term Investments | $211.6M | -53.0% |
| Accounts Receivable | $150.8M | +22.7% |
| Current Assets | $1.10B | -13.3% |
| Total Assets | $1.60B | -0.6% |
| Current Liabilities | $498.0M | +22.2% |
| Total Liabilities | $570.1M | +20.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $242.4M | +50.9% |
| Capital Expenditures | $5.7M | -37.9% |
| Investing Cash Flow | $206.1M | +431.2% |
| Financing Cash Flow | -$436.7M | -549.2% |
| Free Cash Flow | $236.7M | +56.2% |
| +292.6% |
| EPS (Basic) | $0.63 | +296.9% |
| EPS (Diluted) | $0.63 | +296.9% |
| Stockholders' Equity |
| $1.03B |
| -9.3% |